A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+

B. W. Tsang, C. J. Mathias, Mark Green

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The cationic gallium(III) complex formed with the bis(4,6- dimethoxy)salicylaldimine of N,N'-bis(3-aminopropyl)ethylenediamine has been investigated as a potential 68Ga radiopharmaceutical for imaging the heart with PET. The 67Ga complex of this ligand was prepared by ligand exchange from 67Ga-acetylacetonate and its biodistribution determined in ether anesthetized rats following intravenous injection. At 1 min postinjection, 1% of the injected dose was found in the heart with heart-to-blood and heart- to-lung ratios of 2.3:1 and 1.9:1, respectively. No clearance of 67Ga radioactivity from the heart was observed over the 1-min to 2-hr time frame studied. The 68Ga complex of this ligand was also prepared and the tracer further evaluated in a PET imaging study with a normal dog. Beyond 20 min postinjection, the heart was clearly delineated in the 68Ga PET images with good heart-to-blood and heart-to-lung contrast. No clearance of myocardial 68Ga radioactivity was observed over the 90-min imaging period, which is consistent with the results obtained in the rat. Gallium-68 complexes of this type may be useful as radiopharmaceuticals for imaging the heart with PET.

Original languageEnglish (US)
Pages (from-to)1127-1131
Number of pages5
JournalJournal of Nuclear Medicine
Volume34
Issue number7
StatePublished - 1993
Externally publishedYes

Fingerprint

Gallium
Radiopharmaceuticals
Myocardium
ethylenediamine
Ligands
Radioactivity
Lung
Intravenous Injections
Ether
Dogs

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

A gallium-68 radiopharmaceutical that is retained in myocardium : 68Ga[(4,6-MeO2sal)2BAPEN]+. / Tsang, B. W.; Mathias, C. J.; Green, Mark.

In: Journal of Nuclear Medicine, Vol. 34, No. 7, 1993, p. 1127-1131.

Research output: Contribution to journalArticle

@article{44604bcf20784298a4a8632e7fa37e3c,
title = "A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+",
abstract = "The cationic gallium(III) complex formed with the bis(4,6- dimethoxy)salicylaldimine of N,N'-bis(3-aminopropyl)ethylenediamine has been investigated as a potential 68Ga radiopharmaceutical for imaging the heart with PET. The 67Ga complex of this ligand was prepared by ligand exchange from 67Ga-acetylacetonate and its biodistribution determined in ether anesthetized rats following intravenous injection. At 1 min postinjection, 1{\%} of the injected dose was found in the heart with heart-to-blood and heart- to-lung ratios of 2.3:1 and 1.9:1, respectively. No clearance of 67Ga radioactivity from the heart was observed over the 1-min to 2-hr time frame studied. The 68Ga complex of this ligand was also prepared and the tracer further evaluated in a PET imaging study with a normal dog. Beyond 20 min postinjection, the heart was clearly delineated in the 68Ga PET images with good heart-to-blood and heart-to-lung contrast. No clearance of myocardial 68Ga radioactivity was observed over the 90-min imaging period, which is consistent with the results obtained in the rat. Gallium-68 complexes of this type may be useful as radiopharmaceuticals for imaging the heart with PET.",
author = "Tsang, {B. W.} and Mathias, {C. J.} and Mark Green",
year = "1993",
language = "English (US)",
volume = "34",
pages = "1127--1131",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - A gallium-68 radiopharmaceutical that is retained in myocardium

T2 - 68Ga[(4,6-MeO2sal)2BAPEN]+

AU - Tsang, B. W.

AU - Mathias, C. J.

AU - Green, Mark

PY - 1993

Y1 - 1993

N2 - The cationic gallium(III) complex formed with the bis(4,6- dimethoxy)salicylaldimine of N,N'-bis(3-aminopropyl)ethylenediamine has been investigated as a potential 68Ga radiopharmaceutical for imaging the heart with PET. The 67Ga complex of this ligand was prepared by ligand exchange from 67Ga-acetylacetonate and its biodistribution determined in ether anesthetized rats following intravenous injection. At 1 min postinjection, 1% of the injected dose was found in the heart with heart-to-blood and heart- to-lung ratios of 2.3:1 and 1.9:1, respectively. No clearance of 67Ga radioactivity from the heart was observed over the 1-min to 2-hr time frame studied. The 68Ga complex of this ligand was also prepared and the tracer further evaluated in a PET imaging study with a normal dog. Beyond 20 min postinjection, the heart was clearly delineated in the 68Ga PET images with good heart-to-blood and heart-to-lung contrast. No clearance of myocardial 68Ga radioactivity was observed over the 90-min imaging period, which is consistent with the results obtained in the rat. Gallium-68 complexes of this type may be useful as radiopharmaceuticals for imaging the heart with PET.

AB - The cationic gallium(III) complex formed with the bis(4,6- dimethoxy)salicylaldimine of N,N'-bis(3-aminopropyl)ethylenediamine has been investigated as a potential 68Ga radiopharmaceutical for imaging the heart with PET. The 67Ga complex of this ligand was prepared by ligand exchange from 67Ga-acetylacetonate and its biodistribution determined in ether anesthetized rats following intravenous injection. At 1 min postinjection, 1% of the injected dose was found in the heart with heart-to-blood and heart- to-lung ratios of 2.3:1 and 1.9:1, respectively. No clearance of 67Ga radioactivity from the heart was observed over the 1-min to 2-hr time frame studied. The 68Ga complex of this ligand was also prepared and the tracer further evaluated in a PET imaging study with a normal dog. Beyond 20 min postinjection, the heart was clearly delineated in the 68Ga PET images with good heart-to-blood and heart-to-lung contrast. No clearance of myocardial 68Ga radioactivity was observed over the 90-min imaging period, which is consistent with the results obtained in the rat. Gallium-68 complexes of this type may be useful as radiopharmaceuticals for imaging the heart with PET.

UR - http://www.scopus.com/inward/record.url?scp=0027193714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027193714&partnerID=8YFLogxK

M3 - Article

C2 - 8315489

AN - SCOPUS:0027193714

VL - 34

SP - 1127

EP - 1131

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -